Task Force Advises Making Gene Patents Exempt from Infringement

The SACGHS task force has suggested that genetic testing patents are not necessary for innovation and may, in some cases, block patient access. However, the recommendations are not final and are being discussed at a meeting in Washington, DC, this week.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.